Zogenix, Inc. (ZGNX) Misses Q3 EPS by 4c, Cuts FY11 Guidance
Tweet
Share
E-mailGet Alerts ZGNX Hot Sheet
Join SI Premium – FREE
Zogenix, Inc. (NASDAQ: ZGNX) reported Q3 EPS of ($0.59), $0.04 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $11.3 million.
Zogenix, Inc. sees FY2011 product gross margin of 41% to 43%, down from 48% to 52%. Zogenix, Inc. sees FY2011 revenue of $39-$41 million, versus prior guidance of $43-$47 million and the consensus of $43.46 million.
Zogenix, Inc. sees FY2011 product gross margin of 41% to 43%, down from 48% to 52%. Zogenix, Inc. sees FY2011 revenue of $39-$41 million, versus prior guidance of $43-$47 million and the consensus of $43.46 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
